Eric M. Dube, CHIEF EXECUTIVE OFFICER at Travere Therapeutics, Inc. (TVTX), sold 21,472 shares at $19.46 ($418K) on 2025-01-22, disclosed to the SEC on 2025-01-23.
Scheduled sale ($418k) by CHIEF EXECUTIVE OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.46 | 10,736 | $209K | 50.0% |
| 2 | $19.46 | 10,736 | $209K | 50.0% |
| Total | $19.46 avg | 21,472 | $418K | 100% |
| Filing → |
| TVTX | SELL | 2026-04-15 | $2.6M | — | Filing → |
| TVTX | SELL | 2026-04-02 | $1.9M | — | Filing → |
| TVTX | SELL | 2026-02-24 | $1.8M | — | Filing → |